General Information of the Compound
| Compound ID |
CP0475335
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(4R,4aS,7R,7aR,12bS,13S)-3-(cyclopropylmethyl)-4a,9,13-trihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-N-methyl-4-phenylbutanamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H38N2O5
|
||||||||||||||||||
| Molecular Weight |
518.654
|
||||||||||||||||||
| Canonical SMILES |
CN([C@@H]1CC[C@@]2(O)[C@H]3[C@@H](O)c4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45)C(=O)CCCc1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H38N2O5/c1-32(24(35)9-5-8-19-6-3-2-4-7-19)22-14-15-31(37)28-26(36)21-12-13-23(34)27-25(21)30(31,29(22)38-27)16-17-33(28)18-20-10-11-20/h2-4,6-7,12-13,20,22,26,28-29,34,36-37H,5,8-11,14-18H2,1H3/t22-,26+,28-,29+,30+,31-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OHUYANWPIDTHBL-GLRSWSGFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor